About Our Laboratory

 

Our laboratory is a CLIA-certified and CAP accredited facility that offers comprehensive cytogenetic diagnosis for acquired chromosome abnormalities. The Cytogenetics Laboratory includes an American Board of Medical Genetics and Genomics-certified clinical cytogeneticist/clinical molecular geneticist, highly knowledgeable laboratory supervisors, and well-experienced staff.

​

AmoyDx (North America) Laboratory is licensed in New York, California, Maryland, Pennsylvania, and Rhode Island.

​

Cytogenetics Laboratory

 

AmoyDx Cytogenetics Laboratory offers cytogenetic and molecular genetic (FISH) diagnoses for acquired chromosome abnormalities. We provide conventional karyotype analysis and fluorescence in situ hybridization (FISH) studies for the detection and characterization of chromosome abnormalities in clinical specimens.

​

• High level of accuracy from experienced certified technologists

• Quick turnaround time

• FISH probes and panels available for the following diseases:

• • Lymphomas

  • MM — Multiple Myeloma

    • MM reflex — for IgH rearrangement study

  • MPN — Myeloproliferative Neoplasms

  • MDS — Myelodysplastic Syndromes

  • CLL — Chronic Lymphocytic Leukemia

  • CML — Chronic Myeloid Leukemia

  • ALL — Acute Lymphocytic Leukemia

  • AML — Acute Myeloid Leukemia

• Board-certified cytogeneticists available for consultation or discussion

​

Molecular Pathology Laboratory

 

AmoyDx Molecular Pathology Laboratory offers molecular diagnostic testing for neoplastic diseases. The laboratory uses a spectrum of molecular techniques and platforms to evaluate nucleic acids isolated from patient samples including PCR, qPCR, sequencing, and fragment analysis.

 

The Molecular Pathology Laboratory works closely with the Cytogenetics Laboratory to provide integrated precision molecular and genomic diagnostic services to patients.